Newsletter May 2019 No.191
Top News
Held the 31st JPMA Policy Seminar.
The JPMA held the 31st JPMA Policy Seminar on March 11, 2019, at the Nihonbashi Mitsui Hall (Chuo-ku, Tokyo) under the theme "What can we do with pharmaceutical innovation: Contributions and expectations of new drugs and future challenges. In Japan, the declining birthrate, aging population, and shrinking population are rapidly changing the structure of diseases, while the "100-year life period" has been proposed, and new wisdom is required to maintain the social security system. The goal is to create an "angel cycle" in which new drug innovation is the starting point for extending healthy life expectancy, increasing the working population and reducing social security costs and burdens, and the financial resources generated as a result of improved tax revenues are invested in new drug innovation. Representatives from each stakeholder group discussed what roles industry, academia, and government should play to achieve this goal.
Topics
- The Office of Pharmaceutical Industry Research Workshop to Commemorate the 20th Anniversary of the Establishment of
- 2019 Life Science Intellectual Property Forum" held with the theme "New Drug Business and Intellectual Property in China
- Information Session on "Cost-Effectiveness Evaluation" Held
- JPMA Media Forum on "value revolution in healthcare
- JPMA Media Forum" held on the theme of "Lifelong Immunization
- Report on the Intellectual Property Committee's mission to Korea
- Held the 2nd Meeting of Code Compliance Managers
- The 10th Workshop on Environmental Technology held.
Policy Research Institute
From JPMA
Pursuing Innovation and Solving Social Issues